🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 415858109 (prev. 45323A201 )
- Market Cap
- Small Cap
- Previous Symbol
- IMMY (changed 1/2/2019)
- Previous Name
- Imprimis Pharmaceuticals, Inc.
Business: Harrow Health, Inc. owns a portfolio of healthcare businesses, including the nation’s leading ophthalmology pharmaceutical compounding business, ImprimisRx. The company holds large equity positions in Eton Pharmaceuticals, Surface Pharmaceuticals, Melt Pharmaceuticals, Mayfield Pharmaceuticals and Radley Pharmaceuticals, companies founded as subsidiaries of Harrow Health. The Company also owns royalty rights in certain 505(b)(2) drug candidates being developed by Eton, Surface, Melt, Mayfield and Radley.
Company Contact
- CEO
- Mark L. Baum
- CFO
- Andrew R. Boll
- Headquarters
- 102 Woodmont Blvd., Suite 610, Nashville, TN 37205
- Phone
- 615-733-4730
- Investor Relations
- Jamie Webb · 615-733-4737 · jwebb@harrowinc.com